1 / 24

HEART FAILURE

HEART FAILURE. Objectives:-. Definition Epidemiology Aetiology Pathophysiology Staging Symptoms & Signs Investigations Treatments Complications. Definition :-. Inability to maintain a cardiac output adequate for the body ’ s need.

quyn-hill
Download Presentation

HEART FAILURE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HEART FAILURE

  2. Objectives:- • Definition • Epidemiology • Aetiology • Pathophysiology • Staging • Symptoms & Signs • Investigations • Treatments • Complications

  3. Definition :- • Inability to maintain a cardiac output adequate for the body’s need. • It is considered to be a clinical syndrome , because despite different causes , it is associated with cardiac dilation and impaired cardiac contractility .

  4. Epidemiology : • It is Primarily a disease of old age , affecting 30% of people over 80 years. • Improvements in the managements of acute MI & chronic heart disease has led to more heart failure rates , because more patients survive to develop it later in life .

  5. Aetiology:- - Causes of Left heart failure : • Inadequate LV filling : -Mitral stenosis . -LV diastolic dysfunction (LVH) • Pressure overload : -Aortic stenosis . -Hypertension . • Volume overload : -Aortic or mitral regurgitation . -High output failure , e.g. anemia • LV muscle disease : -Myocardial infarction . -Cardiomyopathy. -Myocarditis .

  6. - Causes of Right heart failure : • Any Cause of LHF . • Pulmonary hypertension (lung disease) . • Atrial septal defect .

  7. Pathophysiology :- 1 Cardiac Damage Cardiac output Neuroendocrine activation Fluid retention Peripheral resistance 2 Ventricular dilatation

  8. Symptoms & Signs : - Left Heart Failure : • Symptoms : - Shortness of breath . - Orthopnea. - PND. • Signs : - Tachypnoea . - Tachycardia . - 3rd heart sound on aus . - Bibasilar pulmonary crepitations .

  9. - Right Heart Failure : • Symptoms : Non specific such as : - Fatigue . - Anorexia . - Nausea . • Signs : - JVP . - Hepatomegly . - Pitting edema (an kles and pedal) . - Ascites . - Functional tricuspid incompetence .

  10. Investigations : • ECG . • Echocardiography . • Chest x ray. • Nuclear isotope scanning . • 24 hr ECG to investigate arrhythmias .

  11. Treatment General Measures Surgical Medical

  12. General Measures :. :. • Treat the underlying cause . • Reduce salt and water intake . • Daily weight . • Treat HTN and CAD aggressively.

  13. .: Medical Treatment :. • Diuretics. • ACE inhibitors . • Angiotensin II receptor antagonist. • B- blockers. • Digoxin .

  14. Diuretics : 1 - Classified into : (A) Loop diuretics e.g. furosomide , bumetanide. - MOA : Inhibit Na reabsorption in the ascending limb of the loop of Henle. - They are potent . - S/E : - Marked renal k loss. - Promote hyperuricemia.

  15. (B) Thiazides e.g. bendroflumethiazide. -MOA : Inhibit Na reabsorption in the distal renal tubule. -Mild diuretics except metolazone which causes excess diuresis. -S/E : -Hypokalemia. - Hyperglycemia & hyperuricemia. (C) K- sparing diuretics e.g. spironolactone. -MOA :Increase Na secretion on the distal nephron and inhibit K secretion. -S/E :Gynaecomastia, nausea and abdominal pain.

  16. ACE Inhibitors : 2 • E.g. captopril , enalapril , lisinopril . • MOA : - Inhibit angiotensin II. - Increase cardiac output by decreasing preload and afterload . - Decrease vascular resistance and PCWP . • Common S/E : - First dose hypotension . - the dose of diuretics 24 hr before first dose . - Start with low dose followed by gradual increase every 1-2 weeks . - Other S/E angioedema and persistant cough.

  17. Studies of LVD (SOLVD) .Enalapril. - Decrease all cause mortality 16% - Decrease mortality from HF 22%

  18. 3 Angiotensin 2 receptor antagonist : e.g. losartan ,valsartan. - They block binding of angiotensin 2 with type 1 receptors. - Do not produce cough. B – blockers : 4 e.g. metoprolol, bisoprolol, carvedilol. - Restricted to patients with chronic stable HF. - ACC guidelines recommend that b-blockers should be routinely prescribed to patients with asymptomatic LV dysfunction unless they have contraindication. 5 Digoxin : - Has +ve inotropic effect . - No mortality benefit.

  19. .: Surgery :. Cardiac transplantation . • Has 90% 1-year survival after surgery . • 75% a live after 5 years. • Death usually due to : 1- operative mortality. 2- organ rejection.

  20. Complications : • Thromboembolism • AF • Ventricular arrythmia

  21. Thank You

  22. Questions • What is New York HF classification ? • What are the C/I of ACE inhibitors ?

More Related